Buscar

25/06/2025 Association of morphine vs. fentanyl prescription dispensation with adverse clinical outcomes
Reyes, C, Pou, MA, Diaz-Torne, C, Carbonell-Abella, C, Brotons, C, Martinez-Laguna, D. Association of morphine vs. fentanyl prescription dispensation with adverse clinical outcomes. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1579634. PMID:40635750. IF:4.800(Q1/2D).
01/06/2025 GOUT CHARACTERISTICS, COMORBIDITIES AND MANAGEMENT IN A LONG PRIMARY CARE DATABASE FROM CATALONIA: THE GOTAP STUDY
Pou, MA, Reyes, C, Martinez-Laguna, D, Tebe, C, Satorra, P, Dalbeth, N, Diaz-Torne, C. GOUT CHARACTERISTICS, COMORBIDITIES AND MANAGEMENT IN A LONG PRIMARY CARE DATABASE FROM CATALONIA: THE GOTAP STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1407. PMID:. IF:20.600(Q1/1D).
01/06/2025 THE YOUNG, THE METABOLIC ANDTHE HYPERTENSIVE. A CLUSTER ANALYSIS OF GOUT CHARACTERISTICS AND COMORBIDITIES
Pou, MA, Reyes, C, Martinez-Laguna, D, Satorra, P, Tebe, C, Dalbeth, N, Diaz-Torne, C. THE YOUNG, THE METABOLIC ANDTHE HYPERTENSIVE. A CLUSTER ANALYSIS OF GOUT CHARACTERISTICS AND COMORBIDITIES. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2148. PMID:. IF:20.600(Q1/1D).
01/06/2025 Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study)
Sanchis, MJ, Guilabert, M, Parker, LA, Caballero-Romeu, JP, Chilet-Rosell, E, Gómez-Pérez, L, Alonso-Coello, P, Cebrián, A, López-Garrigós, M, Moral, I, Ronda-Pérez, E, Canelo-Aybar, C, Hernández-Aguado, I, Párraga, I, Del Campo-Giménez, M, Lumbreras, B. Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study). Bmj Evidence-Based Medicine. 2025; 30(3)DOI:10.1136/bmjebm-2024-113113. PMID:39797674. IF:7.600(Q1/1D).
01/03/2025 Patient's experience as a tool in analyzing primary care in Catalonia
Iruela, A, Moral, I, Gálvez, G, Jimenez, LM, Manzanera, R. Patient's experience as a tool in analyzing primary care in Catalonia. Journal Of Healthcare Quality Research. 2025; 40(2)DOI:10.1016/j.jhqr.2024.10.002. PMID:39547860. IF:(Q/D).
01/01/2025 Effectiveness of the SYNCHRONIZE plus Brief Intervention in Improving Mediterranean Diet Adherence, Nutritional Quality and Intake Pattern in Persons with Fibromyalgia and Chronic Fatigue Syndrome
Carrasco-Querol, N, Cabricano-Canga, L, Hernández, NB, Martín-Borràs, C, Goncalves, AQ, Vila-Marti, A, Ribot, B, Sola, J, Valls-Llobet, C, Angelats, RC, Monteso-Curto, P, Blanco, EC, Ariza, MP, Rey, SC, Paga, LP, Sanchís, MD, Fernández-Sáez, J, Llorca, MRD, Martín, CA. Effectiveness of the SYNCHRONIZE plus Brief Intervention in Improving Mediterranean Diet Adherence, Nutritional Quality and Intake Pattern in Persons with Fibromyalgia and Chronic Fatigue Syndrome. Nutrients. 2025; 17(1)DOI:10.3390/nu17010011. PMID:39796445. IF:5.000(Q1/2D).
31/12/2024 Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe
Herrera, D, Sanz, M, Shapira, L, Brotons, C, Chapple, I, Frese, T, Graziani, F, Hobbs, FDR, Huck, O, Hummers, E, Jepsen, S, Kravtchenko, O, Madianos, P, Molina, A, Ungan, M, Vilaseca, J, Windak, A, Vinker, S. Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe. European Journal of General Practice. 2024; 30(1)DOI:10.1080/13814788.2024.2320120. PMID:38511739. IF:2.500(Q1/1D).
01/11/2024 Recomendaciones preventivas vasculares. Actualización PAPPS 2024.
Orozco-Beltrán D, Brotons-Cuixart C, Banegas JR, Gil-Guillen VF, Cebrián-Cuenca AM, Martín-Rioboó E, Jordá-Baldó A, Vicuña J, Navarro-Pérez J. Recomendaciones preventivas vasculares. Actualización PAPPS 2024.. Atencion Primaria. 2024; 56 Suppl 1(Suppl 1)DOI:10.1016/j.aprim.2024.103123. PMID:39613355. IF:(Q/D).
01/08/2024 Dexketoprofen Trometamol and Tramadol Hydrochloride Fixed-Dose Combination in Moderate to Severe Acute Low Back Pain: A Phase IV, Randomized, Parallel Group, Placebo, Active-Controlled Study (DANTE)
Varrassi, G, Hanna, M, Coaccioli, S, Fabrizzi, P, Baldini, S, Kruljac, I, Brotons, C, Perrot, S. Dexketoprofen Trometamol and Tramadol Hydrochloride Fixed-Dose Combination in Moderate to Severe Acute Low Back Pain: A Phase IV, Randomized, Parallel Group, Placebo, Active-Controlled Study (DANTE). Pain and Therapy. 2024; 13(4)DOI:10.1007/s40122-024-00623-4. PMID:38922520. IF:3.300(Q2/4D).
29/06/2024 Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season
de la Cueva, IS, Gerber, JE, Hastie, A, Brotons, C, Panzer, F, Pircon, JY, Talsma, P, Eckermann, T, Nikic, V, Gomez, XM, Alsdurf, H. Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season. DRUG SAFETY. 2024; 47(11)DOI:10.1007/s40264-024-01456-y. PMID:38949714. IF:3.800(Q1/2D).
30/05/2024 Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study)
Parker, LA, Caballero-Romeu, JP, Chilet-Rosell, E, Hernandez-Aguado, I, Gómez-Pérez, L, Alonso-Coello, P, Cebrián, A, López-Garrigós, M, Moral-Pélaez, I, Ronda, E, Gilabert, M, Canelo-Aybar, C, Párraga-Martínez, I, del Campo-Giménez, M, Lumbreras, B. Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). PLoS One. 2024; 19(5)DOI:10.1371/journal.pone.0303203. PMID:38814917. IF:2.600(Q2/4D).
01/05/2024 Validación del modelo IberScore en una población de atención primaria
Fernández-Labandera Ramos C., Moral I., Brotons C., Quevedo Aguado L., Coca Prieto I., Valdivielso P., Sánchez Chaparro M.Á.. Validación del modelo IberScore en una población de atención primaria. Clinica E Investigacion En Arteriosclerosis. 2024; 36(3)DOI:10.1016/j.arteri.2023.12.003. PMID:38220535. IF:(Q/D).
18/03/2024 European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism
Carter, P, Fuat, A, Haas, S, Smyth, Elizabeth, Brotons, C, Cools, F, Bauersachs, R, Hobbs, R. European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism. Bmc Primary Care. 2024; 25(1)DOI:10.1186/s12875-024-02314-7. PMID:38500048. IF:2.600(Q1/1D).
01/01/2024 Manejo integral de los factores de riesgo en enfermedad arterial periférica
Cuixart C.B., González P.B., Pelaez I.M., Ruiz D.S.. Manejo integral de los factores de riesgo en enfermedad arterial periférica. Fmc Formacion Medica Continuada En Atencion Primaria. 2024; 31(1)DOI:10.1016/j.fmc.2023.07.003. PMID:. IF:(Q/D).
01/01/2024 Efectividad del asistente clínico en el control de pacientes hipertensos y diabéticos en atención primaria
Galán M., Sellarès J., Monteserín R., Vicuña J., Moral I., Brotons C.. Efectividad del asistente clínico en el control de pacientes hipertensos y diabéticos en atención primaria. Atencion Primaria. 2024; 56(6)DOI:10.1016/j.aprim.2023.102853. PMID:38244288. IF:1.600(Q2/4D).
16/08/2023 Luces y sombras de la Guía Europea ESC-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
Martín-Rioboó E., Brotons-Cuixart C., García A.R., Sanz F.V., Vargas M.F., Amengual A.M., Garrote J.A.D., Vicente M.C.S., Banegas J.R., Carratalá V.P.. Luces y sombras de la Guía Europea ESC-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:. IF:(Q/D).
16/08/2023 Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Martín-Rioboó E, Brotons-Cuixart C, Ruiz García A, Villafañe Sanz F, Frías Vargas M, Moyá Amengual A, Divisón Garrote JA, Seoane Vicente MC, Banegas JR, Pallarés Carratalá V. Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:37921403. IF:(Q/D).
01/08/2023 An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, XD, Targher, G, Byrne, CD, Somers, V, Kim, SU, Chahal, CAA, Wong, VWS, Cai, JJ, Shapiro, MD, Eslam, M, Steg, PG, Sung, KC, Misra, A, Li, JJ, Brotons, C, Huang, YL, Papatheodoridis, GV, Sun, AJ, Yilmaz, Y, Chan, WK, Huang, H, Mendez-Sanchez, N, Alqahtani, SA, Cortez-Pinto, H, Lip, GYH, de Knegt, RJ, Ocama, P, Romero-Gomez, M, Fudim, M, Sebastiani, G, Son, JW, Ryan, JD, Ikonomidis, I, Treeprasertsuk, S, Pastori, D, Lupsor-Platon, M, Tilg, H, Ghazinyan, H, Boursier, J, Hamaguchi, M, Nguyen, MH, Fan, JG, Goh, GBB, Al Mahtab, M, Hamid, S, Perera, N, George, J, Zheng, MH. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatology International. 2023; 17(4)DOI:10.1007/s12072-023-10543-8. PMID:37204656. IF:5.900(Q1/2D).
19/07/2023 Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial
Guan, YF, Puenpatom, A, Johnson, MG, Zhang, Y, Zhao, YJ, Surber, J, Weinberg, A, Brotons, C, Kozlov, R, Lopez, R, Coetzee, K, Santiaguel, J, Du, JJ, Williams-Diaz, A, Brown, M, Paschke, A, De Anda, C, Norquist, JM. Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial. CLINICAL INFECTIOUS DISEASES. 2023; 77(11)DOI:10.1093/cid/ciad409. PMID:37466374. IF:8.200(Q1/1D).
01/06/2023 Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)
Herrera, D, Sanz, M, Shapira, L, Brotons, C, Chapple, I, Frese, T, Graziani, F, Hobbs, FDR, Huck, O, Hummers, E, Jepsen, S, Kravtchenko, O, Madianos, P, Molina, A, Ungan, M, Vilaseca, J, Windak, A, Vinker, S. Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe). JOURNAL OF CLINICAL PERIODONTOLOGY. 2023; 50(6)DOI:10.1111/jcpe.13807. PMID:36935200. IF:5.800(Q1/1D).
01/05/2023 Normal Infrarenal Aortic Diameter in Men and Women in a Mediterranean Area
Gené Mola A., Casasa A., Puig Reixach T., de La Figuera M., Jimenez M.J., Fité Matamoros J., Roman Escudero J., Bellmunt Montoya S.. Normal Infrarenal Aortic Diameter in Men and Women in a Mediterranean Area. ANNALS OF VASCULAR SURGERY. 2023; 92DOI:10.1016/j.avsg.2022.12.087. PMID:36639098. IF:1.400(Q3/6D).
01/11/2022 Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis
Checa, C, Canelo-Aybar, C, Suclupe, S, Ginesta-Lopez, D, Berenguera, A, Castells, X, Brotons, C, Posso, M. Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(21)DOI:10.3390/ijerph192113823. PMID:36360704. IF:4.614(Q1/3D).
01/09/2022 Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021
Brotons, C, Camafort, M, Castellanos, MD, Clara, A, Cortes, O, Rodriguez, AD, Elosua, R, Gorostidi, M, Hernandez, AM, Herranz, M, Justo, S, Lahoz, C, Nino, P, Pallares-Carratala, V, Pedro-Botet, J, Perez, AP, Royo-Bordonada, MA, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P. Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021. Angiologia. 2022; 74(5)DOI:10.20960/angiologia.00411. PMID:. IF:(Q/D).
01/07/2022 Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention
Brotons, C, Camafort, M, Castellanos, MD, Clara, A, Cortes, O, Rodriguez, AD, Elosua, R, Gorostidi, M, Hernandez, AM, Herranz, M, Justo, S, Lahoz, C, Nino, P, Pallares-Carratala, V, Pedro-Botet, J, Perez, AP, Royo-Bordonada, MA, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Clinica E Investigacion En Arteriosclerosis. 2022; 34(4)DOI:10.1016/j.arteri.2022.03.003. PMID:35906022. IF:(Q/D).
01/05/2022 Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention
Brotons, C, Camafort, M, Castellanos, MD, Clara, A, Cortes, O, Rodriguez, AD, Elosua, R, Gorostidi, M, Hernandez, AM, Herranz, M, Justo, S, Lahoz, C, Nino, P, Pallares-Carratala, V, Pedro-Botet, J, Perez, AP, Royo-Bordonada, MA, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Hipertension Y Riesgo Vascular. 2022; 39(2)DOI:10.1016/j.hipert.2022.02.003. PMID:35331672. IF:(Q/D).
01/01/2022 EUROPREV (Red Europea de Prevención)
Brotons C., Martins C.. EUROPREV (Red Europea de Prevención). Atencion Primaria. 2022; 54DOI:10.1016/j.aprim.2022.102443. PMID:36435584. IF:(Q/D).
01/01/2022 Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2
Brotons C., Moral-Peláez I., Vicuña J., Ameixeiras C., Fernández-Lavandera C., Sánchez-Chaparro M.Á.. Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2. Clinica E Investigacion En Arteriosclerosis. 2022; 35(3)DOI:10.1016/j.arteri.2022.09.003. PMID:36344347. IF:(Q/D).
01/01/2022 La complejidad del papel del colesterol unido a HDL
Brotons C., Moral I., Vicuña J.. La complejidad del papel del colesterol unido a HDL. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.08.004. PMID:36228961. IF:5.900(Q1/3D).
01/01/2022 Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS
Orozco-Beltrán D., Brotons Cuixart C., Banegas Banegas J.R., Gil Guillén V.F., Cebrián Cuenca A.M., Martín Rioboó E., Jordá Baldó A., Vicuña J., Navarro Pérez J.. Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS. Atencion Primaria. 2022; 54(Suppl 1)DOI:10.1016/j.aprim.2022.102444. PMID:36435583. IF:(Q/D).
01/01/2022 Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study
Orozco-Beltrán D., Morales C., Artola-Menéndez S., Brotons C., Carrascosa S., González C., Baro Ó., Aliaga A., de Campos K.F., Villarejo M., Hurtado C., Álvarez-Ortega C., Gómez-García A., Cedenilla M., Fernández G.. Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study. Jmir Diabetes. 2022; 7(4)DOI:10.2196/40377. PMID:. IF:(Q/D).
01/01/2022 Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
Mostaza J.M., Suárez-Fernández C., Cosín-Sales J., Gómez-Huelgas R., Brotons C., Araujo F.P., Borrayo G., Ruiz E., Pérez P., Espinosa J., Sobrino J., Posé A., Arroyo Díaz J.A., García Vallejo O., Cubo Romano M.P., Jansen Chaparro S., Cabezón Mariscal J., Rico Corral M.A., Abellán Alemán J., Orozco Beltrán D., Escobar Jimenez L., Valdivieso Felices P., Pedro-Botet Montoya J.C., Masana Marín L., Guijarro C., Díaz Rodríguez Á., Díaz Díaz J.L., De la Peña Fernández A., Coloma Bazán E., Cuenca Acevedo R., Suárez Fernández C., Civeira F., Castellano Vázquez J.M., Mostaza Prieto J.M., Suárez Tembra M., Alfonso Megido J., Castiella Herrero J., Tamarit J.J., Martínez-Hervás Alonso M.Á., Carrasco Franco F.J., Álvarez Sala L., Calderón Sandubete E., Rovira Daudi E., Bonilla Rovira F., Murcia Zaragoza J.M., Cuixart Costa L., Bianchi Llave J.L., Álvarez Sánchez C., Marqués Da Silva P., Cunha V., Santos C., Araujo F., Moura J., Rosas Peralta M.. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial. BMC Cardiovascular Disorders. 2022; 22(1)DOI:10.1186/s12872-022-03013-w. PMID:36550424. IF:2.100(Q3/8D).
01/01/2024 Medical abortion provision and quality of care: What can be learned from feminist activists?
Larrea, S, Palencia, L, Borrell, C. Medical abortion provision and quality of care: What can be learned from feminist activists?. Health Care for Women International. 2024; 45(1)DOI:10.1080/07399332.2021.1969573. PMID:34652257. IF:0.900(Q3/7D).
01/01/2024 Understanding the relationship between gender and mental health in adolescence: the Gender Adherence Index (GAI)
Xavier C.-B., Guille P., Gemma S., Esther S.-L., Angel M.-H., Asun P.-B.. Understanding the relationship between gender and mental health in adolescence: the Gender Adherence Index (GAI). EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2024; 33(1)DOI:10.1007/s00787-023-02150-7. PMID:36763181. IF:4.900(Q1/1D).
01/08/2023 Reliability and cross-country equivalence of the 8-item version of the Patient Health Questionnaire (PHQ-8) for the assessment of depression: results from 27 countries in Europe
de la Torre, JA, Vilagut, G, Ronaldson, A, Valderas, JM, Bakolis, I, Dregan, A, Molina, AJ, Navarro-Mateu, F, Perez, K, Bartoll-Roca, X, Elices, M, Perez-Sola, V, Serrano-Blanco, A, Martin, V, Alonso, J. Reliability and cross-country equivalence of the 8-item version of the Patient Health Questionnaire (PHQ-8) for the assessment of depression: results from 27 countries in Europe. Lancet Regional Health-Europe. 2023; 31DOI:10.1016/j.lanepe.2023.100659. PMID:37332385. IF:13.600(Q1/1D).
26/07/2023 Socioeconomic inequalities in COVID-19 incidence during the first six waves in Barcelona
Martinez-Beneito, MA, Mari-Dell'Olmo, M, Sanchez-Valdivia, N, Rodriguez-Sanz, M, Perez, G, Pasarin, MI, Rius, C, Artazcoz, L, Prieto, R, Perez, K, Borrell, C. Socioeconomic inequalities in COVID-19 incidence during the first six waves in Barcelona. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023; 52(6)DOI:10.1093/ije/dyad105. PMID:37494962. IF:6.400(Q1/1D).
07/07/2023 Social inequalities in self-perceived health in Chile, does the urban environment matter?: a cross-sectional study
López-Contreras N., Puig-Barrachina V., Vives A., Olave-Müller P., Gotsens M.. Social inequalities in self-perceived health in Chile, does the urban environment matter?: a cross-sectional study. Archives of Public Health. 2023; 81(1)DOI:10.1186/s13690-023-01136-w. PMID:37420299. IF:3.200(Q2/3D).
04/07/2023 Evaluation of a smoke-free beaches intervention in Barcelona: a quasi-experimental study
Valmayor S., González K., López M.J., Lacera P., Giménez P., Rumín-Caparrós A., Pasarín M.I., Henderson E., Díez E.. Evaluation of a smoke-free beaches intervention in Barcelona: a quasi-experimental study. TOBACCO CONTROL. 2023; DOI:10.1136/tc-2022-057873. PMID:37402576. IF:4.000(Q1/2D).
01/07/2023 Gender-based differences in the meanings and uses of housing for health and everyday life: An intersectional approach
Vasquez-Vera, C, Fernandez, A, Sanchez-Ledesma, E, Bennett, M, Borrell, C. Gender-based differences in the meanings and uses of housing for health and everyday life: An intersectional approach. WOMENS STUDIES INTERNATIONAL FORUM. 2023; 99DOI:10.1016/j.wsif.2023.102761. PMID:. IF:1.500(Q2/5D).
14/06/2023 Community outbreak of COVID-19 among people who use drugs attending a harm reduction centre in Barcelona, Spain
Sánchez-Valdivia N., Barbaglia M.G., Olivella-Cirici M., Marcos, NG, Gotsens M., Albaina, AG, Rius C., Bartroli M., Pérez G.. Community outbreak of COVID-19 among people who use drugs attending a harm reduction centre in Barcelona, Spain. Harm Reduction Journal. 2023; 20(1)DOI:10.1186/s12954-023-00804-y. PMID:37316829. IF:4.000(Q1/2D).
01/06/2023 Healthy and Equitable Interpersonal Relationships, Health Inequalities and Socio-Educational Interventions: A Conceptual Framework for Action
Forcadell-Díez L., Martinez, OJ, Abiétar D.G., López M.J., Sánchez-Martínez F., Perez G.. Healthy and Equitable Interpersonal Relationships, Health Inequalities and Socio-Educational Interventions: A Conceptual Framework for Action. JOURNAL OF SCHOOL HEALTH. 2023; 93(6)DOI:10.1111/josh.13318. PMID:36917972. IF:1.800(Q2/4D).